Early Detection of Five Common Cancers Using the ctDNA Analysing Test
NCT05227261 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 9057
Last updated 2025-02-18
Summary
This is a multi-centre, prospective cohort study, aiming to evaluate a blood test in early detection of the four common cancers, based on the investigation of the circulating tumour DNA (ctDNA).
Primary objective: To evaluate the performance characteristics of the blood ctDNA test in early detecting cancers.
Secondary objectives:
* To evaluate the performance characteristics of the test in determining the origin of tumour, as compared to the findings of the imaging diagnostic tests.
* To determine the risk of cancers development in the high-risk population, as compared to that in the moderate-risk group.
Conditions
- Cancer, Lung
- Cancer, Breast
- Cancer Liver
- Cancer, Colorectal
- Liquid Biopsy
- Circulating Tumour DNA
- Cancer, Gastric
Sponsors & Collaborators
-
Medical University of Ho Chi Minh City
collaborator UNKNOWN -
Hanoi Medical University
collaborator OTHER -
Hanoi Oncology Hospital
collaborator UNKNOWN -
Hue Central Hospital
collaborator OTHER -
Da Nang Oncology Hospital
collaborator UNKNOWN -
Thong Nhat Dong Nai General Hospital
collaborator UNKNOWN -
Dong Nai General Hospital
collaborator UNKNOWN -
Van Hanh General Hospital
collaborator OTHER -
Can Tho Oncology Hospital
collaborator UNKNOWN -
Medic Medical Center
collaborator UNKNOWN -
Le Van Thinh Hospital
collaborator UNKNOWN -
People's Hospital 115
collaborator UNKNOWN -
Xuyen A Hospital
collaborator UNKNOWN -
Medical Genetics Institute
collaborator UNKNOWN -
Gene Solutions
lead INDUSTRY
Eligibility
- Min Age
- 40 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-04-10
- Primary Completion
- 2023-04-10
- Completion
- 2024-04-10
Countries
- Vietnam
Study Locations
More Related Trials
-
Detection of Tumor DNA in Blood Samples From Cancer Patients
NCT02288754 ·Status: UNKNOWN
-
Assessing Systemic Treatment and ctDNA Monitoring Efficacy in Metastatic Cancer Patients Using K4Care Testing.
NCT06929910 ·Status: RECRUITING
-
ctDNA Monitoring to Predict the Efficacy of TNT for Rectal Cancer
NCT06589388 ·Status: RECRUITING
-
Role of ctDNA in Genetic Profiling & Outcomes for Advanced BTC
NCT07142226 ·Status: RECRUITING
-
Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers
NCT02838836 ·Status: RECRUITING
-
A Prospective, Multi-center Clinical Study to Establish Multi-Cancer Early Detection Platform Through the Analysis of Whole Genome Sequencing of Circulating DNA in Cancer Patients and Healthy Volunteers
NCT06231953 ·Status: RECRUITING
-
Pan-canceR Early DetectIon projeCT (PREDICT)
NCT04817306 ·Status: UNKNOWN
-
Detection of CTC and ctDNA in the Diagnosis of Metastasis in Gastric Cancer
NCT05208372 ·Status: UNKNOWN
-
Tumor Cell and DNA Detection in the Blood, Urine, and Bone Marrow
NCT03551951 ·Status: RECRUITING
-
Monitoring Minimal Residual Disease in Gastric Cancer by Liquid Biopsy Study Description
NCT05029869 ·Status: ACTIVE_NOT_RECRUITING
-
CfDNA in Hereditary And High-risk Malignancies 2
NCT06726642 ·Status: RECRUITING
-
Early Detection and Post-operative Monitoring of Gastric Cancer
NCT06232395 ·Status: RECRUITING
-
AssesSment of Early-deteCtion basEd oN liquiD Biopsy in Hepatobiliary Cancer Malignancies
NCT04835675 ·Status: COMPLETED
-
Circulating Cell-free DNA as a Predictive Biomarker for Hepatocelluar Carcinoma.
NCT02036216 ·Status: UNKNOWN
-
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
NCT04354064 ·Status: RECRUITING
-
Gastric Cancer Early Detection by Multi-dimensional Analysis of cfDNA
NCT05668910 ·Status: UNKNOWN
-
Urine-DNA Biomarkers in Detecting Bladder Cancer
NCT03066310 ·Status: COMPLETED
-
ctDNA in Genetic Profiling and Clinical Outcomes of Advanced Biliary Tract Cancer
NCT07151118 ·Status: RECRUITING
-
AssesSment of Early-deteCtion basEd oN liquiD Biopsy in GASTRIC Cancer, ASCEND-Gastric
NCT05224596 ·Status: UNKNOWN
-
HCC Screening Using DNA Methylation Changes in ctDNA
NCT03483922 ·Status: COMPLETED
-
Detection Evaluation of a Novel Blood-based DNA Methylation Assay in Early-stage Hepatocellular Carcinoma Patients
NCT05343832 ·Status: UNKNOWN
-
Potential Clinical Utilities of Circulating Tumor DNA in Advanced HER2 Negative Gastric Cancer
NCT05513144 ·Status: UNKNOWN
-
Detection of Tumor DNA in Blood Samples From Patients With Early Stage Cancer and "Healthy Controls"
NCT03071809 ·Status: TERMINATED
-
Circulating Tumor DNA Exposure in Peripheral Blood
NCT03517332 ·Status: UNKNOWN
-
Circulating Free DNA Analysis in Gastrointestinal Cancer, Genitourinary Cancer, Rare Cancer
NCT02067754 ·Status: COMPLETED